Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$41,313
-$2,173 QoQ
Shares Held
717
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,344
of 2,506 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Wealth Partners holds $2,314,197 across 10 Drug Manufacturers - General names. BMY ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,056 | $1,020,651 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,121 | $658,048 | |
| 3 | LLY |
ELI LILLY & Co
|
353 | $423,398 | |
| 4 | JNJ |
Johnson & Johnson
|
444 | $112,762 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
717 | $41,313 | |
| 6 | GSK |
GSK plc
|
456 | $23,903 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
110 | $13,897 | |
| 8 | AMGN |
Amgen Inc
|
31 | $11,225 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,313 | 717 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $43,486 | 717 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $38,674 | 717 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $32,336 | 717 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $4,675 | 101 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $6,525 | 107 | Shares | Sole | 2026-02-04 | |
| 2024-12-31 | $7,918 | 140 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||